I have heard that Zicam purposely withheld consumer complaints about loss of smell from the FDA. Is this true?
Matrixx has always cooperated fully with the FDA, willingly shared all information requested by the FDA, and fully complied with its understanding of the FDA’s regulations. Any reports to the contrary are simply not true. As required by FDA regulations, Matrixx has always maintained detailed records of all consumer complaints and followed up with them. In the past four years the FDA has conducted two audits of the company, most recently in May 2009. During each audit, Matrixx made available to the FDA all adverse event complaints received by the company, along with complaint trends. These included all consumer complaints alleging loss or diminishment of the sense of smell.
